Anti–Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema

Volume: 134, Issue: 12, Pages: 1429 - 1429
Published: Dec 1, 2016
Abstract

Importance

Post hoc analyses from the Diabetic Retinopathy Clinical Research Network randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME) might influence interpretation of study results.

Objective

To provide additional outcomes comparing 3 anti–vascular endothelial growth factor (VEGF) agents for DME.

Design, Setting, and Participants

Post hoc analyses performed...
Paper Details
Title
Anti–Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema
Published Date
Dec 1, 2016
Volume
134
Issue
12
Pages
1429 - 1429
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.